Nicole Vincellette

5PUBLICATIONS
78CO-AUTHORS
Medical infection agents (incl. prions)Medical molecular engineering of nucleic acids and proteinsHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 24, 2026
Targeting TGFBR1 with the Investigational Inhibitor TP-6379 Improves Hematopoiesis in Low-Risk MDS Ex Vivo.

|Feb 11, 2026
Prognostic Model Combining Mutational and Cytogenetic Profiles in Acute Myeloid Leukemia Treated with Venetoclax and Hypomethylating Agents.

Dimitrios Drekolias, Fatima Tuz Zahra, Caroline Fileni

|May 07, 2024
Trisomy 8 Defines a Distinct Subtype of Myeloproliferative Neoplasms Driven by the MYC-Alarmin Axis.

Nicole D Vincelette, Xiaoqing Yu, Andrew T Kuykendall

|Sep 13, 2023
CK1δ and CK1ε Signaling Sustains Mitochondrial Metabolism and Cell Survival in Multiple Myeloma.

Karen L Burger, Mario R Fernandez, Mark B Meads

|Feb 25, 2023
Oxidized Mitochondrial DNA Engages TLR9 to Activate the NLRP3 Inflammasome in Myelodysplastic Syndromes.

Grace A Ward, Robert P Dalton, Benjamin S Meyer

Pageof 1

Frequent Collaborators

3 joint publications

Erika A Eksioglu

2 joint publications

Grace Ward

2 joint publications

Robert P Dalton

2 joint publications

Rinzine Sammut